Resources | NITAG RESOURCE CENTER

2024 ∙ ATAGI

ATAGI statement on the administration of seasonal influenza vaccines in 2024

2024 ∙ STIKO

The STIKO recommendation on vaccination against dengue with the Qdenga vaccine

2024 ∙ SAGE

Dengue Vaccine (TAK-003) GRADE tables

2024 ∙ SAGE

Dengue Evidence to Recommendation

2024 ∙ SAGE

WHO position paper on dengue vaccines – May 2024

2024 ∙ NACI

Economic Evidence Supplementary Appendix to the Recommendations for Public Health Programs on the Use of Pneumococcal Vaccines in Children, Including the Use of 15-Valent and 20-Valent Conjugate Vaccines

2024 ∙ NACI

Recommendations for public health programs on the use of pneumococcal vaccines in children, including the use of 15-valent and 20-valent conjugate vaccines

2024 ∙ JCVI

JCVI statement on COVID-19 vaccination in spring 2024 and considerations on future COVID-19 vaccination

2024

Considerations to inform country COVID-19 vaccination decision-making

2024 ∙ NACI

Guidance on an additional dose of COVID-19 vaccines in the spring for individuals at high risk of severe illness due to COVID-19